Side population cells in human gallbladder cancer cell line GBC-SD regulated by TGF-β-induced epithelial-mesenchymal transition

Abstract

Mounting evidence has shown that side population (SP) cells are enriched for cancer stem cells (CSCs) responsible for cancer malignancy. In this study, SP technology was used to isolate a small subpopulation of SP cells in human gallbladder cancer cell line GBC-SD, and SP cells which had superior potential for proliferation in vitro and tumorigenesis in vivo were identified. Importantly, the abundance of GBC-SD SP cells was increased by a transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition (EMT), and this effect was accompanied with a strong up-regulation of ABCG2 mRNA expression, and a decreased sensitivity to mitoxantrone. SP cells were restored upon the removal of TGF-β and the reversion of the cells to an epithelial phenotype, and smad3-specific siRNA reduced SP abundance in response to TGF-β. In conclusion, TGF-β-induced EMT by smad-dependent signaling pathway promotes cancer development and anti-cancer drug resistant phenotype by augmenting the abundance of GBC-SD SP cells, and a better understanding of mechanisms involved in TGF-β-induced EMT may provide a novel strategy for preventing cancer progression.

Keywords

side population cells / transforming growth factor-β / epithelial-mesenchymal transition

References

[1] ChanK.M., YehT.S., YuM.C., et al.. Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion. World J Surg, 2005, 29(1): 72-75

[2] KayaharaM., NagakawaT.. Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients. Cancer, 2007, 110(3): 572-580

[3] YeeK., SheppardB.C., DomreisJ., et al.. Cancers of the gallbladder and biliary ducts. Oncology (Williston Park), 2002, 16(7): 939-946

[4] LiC., HeidtD.G., DalerbaP., et al.. Identification of pancreatic cancer stem cells. Cancer Res, 2007, 67(3): 1030-1037

[5] O’BrienC.A., PollettA., GallingerS., et al.. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007, 445(7123): 106-110

[6] ReyaT., MorrisonS.J., ClarkeM.F., et al.. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414(6859): 105-111

[7] ChristiansenJ.J., RajasekaranA.K.. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res, 2006, 66(17): 8319-8326

[8] TsujiT., IbaragiS., HuG.F.. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res, 2009, 69(18): 7135-7139

[9] Kudo-SaitoC., ShirakoH., TakeuchiT., et al.. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell, 2009, 15(3): 195-206

[10] KomuroA., YashiroM., IwataC., et al.. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling. J Natl Cancer Inst, 2009, 101(8): 592-604

[11] KiyonoK., SuzukiH.I., MorishitaY., et al.. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma. Cancer Sci, 2009, 100(10): 1809-1816

[12] DerynckR., ZhangY.E.. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 2003, 425(6958): 577-584

[13] ArumugamT., RamachandranV., FournierK.F., et al.. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res, 2009, 69(14): 5820-5828

[14] MoustakasA., HeldinC.H.. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci, 2007, 98(10): 1512-1520

[15] ZavadilJ., BottingerE.P.. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 2005, 24(37): 5764-5774

[16] SavagnerP.. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays, 2001, 23(10): 912-923

[17] GoodellM.A., BroseK., ParadisG., et al.. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med, 1996, 183(4): 1797-1806

[18] YehY.C., WangC.Z., TangM.J.. Discoidin domain receptor 1 activation suppresses alpha2beta1 integrin-dependent cell spreading through inhibition of Cdc42 activity. J Cell Physiol, 2009, 218(1): 146-156

[19] WulfG.G., LuoK.L., JacksonK.A., et al.. Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells. Haematologica, 2003, 88(4): 368-378

[20] GoodellM.A.. Multipotential stem cells and “side population” cells. Cytotherapy, 2002, 4(6): 507-508

[21] ThieryJ.P.. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol, 2003, 15(6): 740-746

[22] ThieryJ.P.. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer, 2002, 2(6): 442-454

[23] HoM.M., NgA.V., LamS., et al.. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res, 2007, 67(10): 4827-4833

[24] MiettinenP.J., EbnerR., LopezA.R., et al.. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol, 1994, 127(6Pt2): 2021-2036

[25] GalA., SjoblomT., FedorovaL., et al.. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene, 2008, 27(9): 1218-1230

[26] RobertsA.B., TianF., ByfieldS.D., et al.. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev, 2006, 17(1–2): 19-27

[27] SaikaS., Kono-SaikaS., TanakaT., et al.. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest, 2004, 84(10): 1245-1258

[28] SaikaS., Kono-SaikaS., OhnishiY., et al.. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol, 2004, 164(2): 651-663

[29] SatoM., MuragakiY., SaikaS., et al.. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest, 2003, 112(10): 1486-1494

[30] GauldieJ., KolbM., AskK., et al.. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac Soc, 2006, 3(8): 696-702

[31] ZhaoJ., ShiW., WangY.L., et al.. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol, 2002, 282(3): L585-593

[32] FukayaR., OhtaS., YamaguchiM., et al.. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett, 2010, 291(2): 150-157

[33] KaiK., D’CostaS., YoonB.I., et al.. Characterization of side population cells in human malignant mesothelioma cell lines. Lung Cancer, 2010, 70(2): 146-151

[34] HaraguchiN., UtsunomiyaT., InoueH., et al.. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells, 2006, 24(3): 506-513

[35] ManiS.A., GuoW., LiaoM.J., et al.. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 2008, 133(4): 704-715

[36] MishraL., DerynckR., MishraB.. Transforming growth factor-beta signaling in stem cells and cancer. Science, 2005, 310(5745): 68-71